196 related articles for article (PubMed ID: 31561267)
1. Single-cell RNA sequencing reveals chemokine self-feeding of myeloma cells promotes extramedullary metastasis.
Geng S; Wang J; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Wang W; Lyu X; Huang Y; Jing H
FEBS Lett; 2020 Feb; 594(3):452-465. PubMed ID: 31561267
[TBL] [Abstract][Full Text] [Related]
2. FAM46C-mediated tumor heterogeneity predicts extramedullary metastasis and poorer survival in multiple myeloma.
Zhang W; Wu C; Geng S; Wang J; Yan C; Zhang X; Zhang JJ; Wu F; Pang Y; Zhong Y; Wang J; Fu W; Huang X; Wang W; Lyu X; Huang Y; Jing H
Aging (Albany NY); 2023 May; 15(9):3644-3677. PubMed ID: 37155154
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Bae MH; Park CJ; Kim BH; Cho YU; Jang S; Lee DH; Seo EJ; Yoon DH; Lee JH; Suh C
Cytometry B Clin Cytom; 2018 May; 94(3):493-499. PubMed ID: 29220877
[TBL] [Abstract][Full Text] [Related]
4. Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal.
Zhang J; Zhong Y
Hematol Oncol; 2015 Jun; 33(2):75-9. PubMed ID: 24395149
[TBL] [Abstract][Full Text] [Related]
5. p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma.
Sheth N; Yeung J; Chang H
Leuk Res; 2009 Oct; 33(10):1357-60. PubMed ID: 19201468
[TBL] [Abstract][Full Text] [Related]
6. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating plasma cells in peripheral blood using deep learning-based morphological analysis.
Chen P; Zhang L; Cao X; Jin X; Chen N; Zhang L; Zhu J; Pan B; Wang B; Guo W
Cancer; 2024 May; 130(10):1884-1893. PubMed ID: 38236717
[TBL] [Abstract][Full Text] [Related]
8. The t(11;14)(q13;q32) translocation as a poor prognostic parameter for autologous stem cell transplantation in myeloma patients with extramedullary plasmacytoma.
Shin HJ; Kim K; Lee JJ; Song MK; Lee EY; Park SH; Kim SH; Jang MA; Kim SJ; Chung JS
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):227-35. PubMed ID: 25812994
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma.
Yu SC; Chen SU; Lu W; Liu TY; Lin CW
Histopathology; 2011 May; 58(6):896-905. PubMed ID: 21401705
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetics in multiple myeloma patients progressing into extramedullary disease.
Besse L; Sedlarikova L; Greslikova H; Kupska R; Almasi M; Penka M; Jelinek T; Pour L; Adam Z; Kuglik P; Krejci M; Hajek R; Sevcikova S
Eur J Haematol; 2016 Jul; 97(1):93-100. PubMed ID: 26432667
[TBL] [Abstract][Full Text] [Related]
11. Cytodiagnosis of extramedullary plasmacytomas.
Goel G; Rai S; Naik R; Gupta A; Baliga P; Sinha R
Acta Cytol; 2010; 54(3):255-8. PubMed ID: 20518407
[TBL] [Abstract][Full Text] [Related]
12. Clinical analysis of 40 multiple myeloma patients with extramedullary plasmacytoma of the head.
Sun WJ; Zhang JJ; An N; Shen M; Huang ZX; Li X
J Int Med Res; 2016 Dec; 44(6):1462-1473. PubMed ID: 28322099
[TBL] [Abstract][Full Text] [Related]
13.
Pang M; Li C; Zheng D; Wang Y; Wang J; Zhang W; Li F; Jing H
Cancer Manag Res; 2020; 12():7857-7865. PubMed ID: 32922084
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CC-chemokine Receptor 7 in Patiens with Multiple Myeloma and Its Relationship with Extramedullary Disease].
Wang YN; Gan SL; Wu FF; Wang WM; Li SQ; Ma J; Guo R; Jiang ZX; Yue BH; Sun H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):476-479. PubMed ID: 28446296
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters.
Gupta L; Suku P; Dash A; Bose P; Sharma P; Mallik N; Sreedharanunni S; Varma N; Jandial A; Malhotra P; Sachdeva MUS
Curr Probl Cancer; 2024 Feb; 48():101025. PubMed ID: 37951052
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
Ryu D; Kim SJ; Hong Y; Jo A; Kim N; Kim HJ; Lee HO; Kim K; Park WY
Clin Cancer Res; 2020 Feb; 26(4):935-944. PubMed ID: 31558476
[TBL] [Abstract][Full Text] [Related]
17. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.
Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW
Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
Abdalla S; May PC; Garimberti E; Naresh KN
Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
[No Abstract] [Full Text] [Related]
19. Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection.
Came N; Nguyen V; Westerman D; Harrison S
Br J Haematol; 2016 Jun; 173(6):947-9. PubMed ID: 26456706
[No Abstract] [Full Text] [Related]
20. Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.
García-Bernal D; Redondo-Muñoz J; Dios-Esponera A; Chèvre R; Bailón E; Garayoa M; Arellano-Sánchez N; Gutierrez NC; Hidalgo A; García-Pardo A; Teixidó J
J Pathol; 2013 Jan; 229(1):36-48. PubMed ID: 22711564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
